U.S. RESEARCH ROUNDUP-Biontech, Honeywell International, Klaviyo

Agree Realty

12/06/2024 08:14

June 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed
companies, including Biontech, Honeywell International and Klaviyo on Wednesday. 
    
    HIGHLIGHTS
                 * Biontech SE  BNTX.O : JP Morgan raises target price to $94 from $90
 
                 * Honeywell International Inc  HON.O : HSBC raises target price to $235 from $200    
 
                 * Klaviyo Inc  KVYO.N : Barclays raises to overweight from equal weight
 
                 * NetApp Inc  NTAP.O : Susquehanna raises target price to $155 from $138        
 
                 * Welltower Inc  WELL.N : Scotiabank raises target price to $110 from $108    
 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical
order. 
    
                 * Academy Sports and Outdoors Inc  ASO.O : Jefferies cuts target price to $68 from $81
 
                 * Academy Sports and Outdoors Inc  ASO.O : TD Cowen cuts target price to $58 from $82
 
                 * Agree Realty Corp  ADC.N : KeyBanc initiates coverage with overweight rating and $68 PT 
 
                 * Apellis Pharmaceuticals Inc  APLS.O : JP Morgan cuts target price to $72 from $79
 
                 * Biontech SE  BNTX.O : JP Morgan raises target price to $94 from $90
 
                 * Bloom Energy Corp  BE.N : RBC raises target price to $15 from $14
 
                 * Broadstone Net Lease Inc  BNL.N : KeyBanc initiates coverage with sector weight rating
 
                 * Caseys General Stores Inc  CASY.O : RBC raises target price to $361 from $322
 
                 * Clearway Energy Inc  CWENa.N : CIBC raises target price to $32 from $31
 
                 * Comerica Inc  CMA.N : RBC cuts target price to $58 from $62
 
                 * First Solar Inc  FSLR.O : Baird raises target price to $344 from $246
 
                 * Gamestop Corp  GME.N : Wedbush cuts target price to $11 from $13.5
 
                 * Honeywell International Inc  HON.O : HSBC raises target price to $235 from $200
 
                 * Intra-Cellular Therapies Inc  ITCI.O : JP Morgan raises target price to $78 from $75
 
                 * Klaviyo Inc  KVYO.N : Barclays raises to overweight from equal weight
 
                 * Klaviyo Inc  KVYO.N : Barclays raises target price to $29 from $25
 
                 * Moderna  MRNA.O : JP Morgan raises target price to $96 from $85
 
                 * NetApp Inc  NTAP.O : JP Morgan raises target price to $130 from $125
 
                 * NetApp Inc  NTAP.O : Susquehanna raises target price to $155 from $138
 
                 * NetApp Inc  NTAP.O : TD Cowen raises target price to $145 from $135
 
                 * Neurocrine Biosciences Inc  NBIX.O : JP Morgan raises target price to $169 from $158
 
                 * Nextera Energy Inc  NEE.N : RBC raises target price to $84 from $74
 
                 * Nextera Energy Partners LP  NEP.N : CIBC raises target price to $35 from $34
 
                 * Oracle Corp  ORCL.N : Barclays raises target price to $160 from $147
 
                 * Protagonist Therapeutics Inc  PTGX.O : JP Morgan raises target price to $39 from $37
 
                 * Realty Income Corp  O.N : KeyBanc initiates coverage with sector weight rating
 
                 * Rockwell Automation Inc  ROK.N : Daiwa Capital Markets cuts target price to $295 from $305
 
                 * Southwest Airlines Co  LUV.N : TD Cowen raises target price to $26 from $25
 
                 * Springworks Therapeutics Inc  SWTX.O : JP Morgan cuts target price to $64 from $77
 
                 * Ultragenyx Pharmaceutical Inc  RARE.O : JP Morgan raises target price to $94 from $92
 
                 * Ventas Inc  VTR.N : Scotiabank raises target price to $52 from $51
 
                 * Welltower Inc  WELL.N : Scotiabank raises target price to $110 from $108
 
                 * Zai Lab Ltd  ZLAB.O : JP Morgan raises target price to $43 from $38
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))